Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Rheumatology and Therapy|August 27, 2021
Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational StudySei Muraoka, Zento Yamada, Mai Kawazoe, et al.
Modern Rheumatology|January 21, 2023
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexateYoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, et al.
Arthritis Research & Therapy|December 2, 2017
Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritisHiroshi Sato, Sei Muraoka, Natsuko Kusunoki, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|April 4, 2006
[Case of dermatomyositis complicated with massive pleural effusion that preceded the myopathy]Hideyuki Iwai, Ryuji Koike, Jun Ogawa, et al.
Arthritis Research & Therapy|June 9, 2009
Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factorM Margarida Souto-Carneiro, Vijayabhanu Mahadevan, Kazuki Takada, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG MiceSatoshi Mizutani, Junko Nishio, Kanoh Kondo, et al.
Arthritis Research & Therapy|October 1, 2011
Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritisKayoko Kaneko, Yoshishige Miyabe, Aiko Takayasu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2024
Comparison of efficacy of romosozumab with denosumab and risedronate in patients newly initiating glucocorticoid therapyMai Kawazoe, Kaichi Kaneko, Shotaro Masuoka, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2026
Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trialMai Kawazoe, Shotaro Masuoka, Kaichi Kaneko, et al.
Modern Rheumatology|January 30, 2023
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitisKen-Ei Sada, Shinya Kaname, Tomoaki Higuchi, et al.
Pageof 13